EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieÄquivalenzstudieOpen Access · CC BY 4.0

Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial

Alexandra Sjöholm iD, Eva Backman iD, Maja Modin, Julia Fougelberg iD, Magdalena Claeson iD, John Paoli iD

Journal of the European Academy of Dermatology and Venereology · 2026

DOI: 10.1111/jdv.70556 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2026. Verfasst von Alexandra Sjöholm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Keratosis, Actinic, Photochemotherapy, Photosensitizing Agents, Sunlight. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish governmental funding of clinical research (ALF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Conventional photodynamic therapy (C‐PDT) with red light is an effective but painful treatment for patients with actinic keratoses (AKs). Simulated daylight PDT (SDL‐PDT) is most likely less painful, but its effectiveness has not been thoroughly investigated.

Objectives

To evaluate if SDL‐PDT is non‐inferior to C‐PDT in terms of effectiveness in the treatment of mild to moderate AKs. Additionally, pain perception, local skin reactions and patient preferences were assessed.

Methods

This single‐centre, non‐inferiority (−8% margin), randomized controlled trial included adults with symmetrically distributed mild to moderate AKs across one or more anatomical sites. These sites were randomly assigned to treatment with a single session of C‐PDT on one half of the affected area and SDL‐PDT on the other half, using 5‐aminolevulinic acid hydrochloride as the prodrug. Pain during illumination was assessed using a 0–10 numeric rating scale (NRS). Patient preferences were recorded through self‐report forms. Follow‐up assessments were conducted at 3 months to evaluate early treatment failure and at 1 year to determine overall clearance rates.

Results

In total, 69 participants with 1458 mild to moderate AKs were treated. Most lesions (89.9%) were located on the face and scalp and were diagnosed through clinical and dermoscopic evaluation. After 1 year, the clearance rate was 71.0% for SDL‐PDT and 85.3% for C‐PDT ( p < 0.001), thus failing to demonstrate non‐inferiority. Illumination was reported to be more painful during C‐PDT (mean NRS score of 6.6) compared with SDL‐PDT (mean NRS score of 0.8) ( p < 0.001). One day after treatment, 98.3% of respondents expressed a preference for SDL‐PDT.

Conclusions

SDL‐PDT showed lower clearance rates than C‐PDT but caused significantly less pain. Although not supported as a primary treatment for AKs, SDL‐PDT may be considered for patients prioritizing treatment tolerability within shared decision‐making. This randomized controlled trial was registered at http://www.researchweb.org/ (Project ID: 264721).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Keratosis, ActinicPhotochemotherapyPhotosensitizing AgentsSunlightHumansAgedAminolevulinic AcidFemaleMaleRed LightMiddle AgedPain MeasurementPatient PreferenceAged, 80 and over

Stichwörter der Autor:innen

actinic keratosisaminolevulinic acidphotodynamic therapyrandomized controlled trialsimulated daylight

Substanzen

Aminolevulinic AcidPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

ORCID-Profile: Alexandra Sjöholm, Eva Backman, Julia Fougelberg, Magdalena Claeson, John Paoli

Förderung

  • Swedish governmental funding of clinical research (ALF)

Zitieren

APA

Sjöholm, A., Backman, E., Modin, M., Fougelberg, J., Claeson, M., & Paoli, J. (2026). Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70556

Vancouver

Sjöholm A, Backman E, Modin M, Fougelberg J, Claeson M, Paoli J. Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70556

BibTeX
@article{Sjholm2026,
  author = {Sjöholm, Alexandra and Backman, Eva and Modin, Maja and Fougelberg, Julia and Claeson, Magdalena and Paoli, John},
  title = {Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  doi = {10.1111/jdv.70556}
}
Kostenlos starten →